LGND

Ligand Pharmaceuticals IncorporatedNASDAQHealthcare

$199.59+2.01%ClosedMarket Cap: $3.98B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-24	Citigroup	—	Buy	—
2026-02-27	Oppenheimer	—	Outperform	—
2026-02-24	HC Wainwright & Co.	—	Buy	—
2025-12-10	Stifel	—	Buy	—
2025-12-10	RBC Capital	—	Outperform	—
2025-11-07	Oppenheimer	—	Outperform	—
2025-11-07	Benchmark	—	Buy	—
2025-11-06	HC Wainwright & Co.	—	Buy	—
2025-09-03	Oppenheimer	—	Outperform	—
2025-09-02	Benchmark	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$9.90	$317.6M	6
Sun Dec 31	$10.31	$370.0M	3
Mon Dec 31	$11.25	$422.4M	1
Tue Dec 31	$14.51	$506.4M	1